Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 2 of 2
Full-Text Articles in Medicine and Health Sciences
Topical Timolol Versus Oral Propranolol For The Treatment Of Hemangioma In Children, Saad M. Abd Elnaby, Tamer A. Sultan, Tamer F. Abd Elaziz
Topical Timolol Versus Oral Propranolol For The Treatment Of Hemangioma In Children, Saad M. Abd Elnaby, Tamer A. Sultan, Tamer F. Abd Elaziz
Menoufia Medical Journal
Objective To evaluate the clinical efficacy and adverse effects of oral propranolol in comparison with topical timolol for the treatment of hemangioma. Background Previous research declares that hemangioma is the most common tumor of infancy and childhood, occurring in 4–10% of white infants. Patients and methods To reach the goal of this research, a prospective randomized study was performed by selecting 20 patients with hemangioma attending the Pediatric Surgery Clinic at Menoufia Main University Hospital and Damanhur National Medical Institute. All patients were subjected to detailed history taking, clinical examination, echocardiogram, complete blood picture, liver and kidney functions, and blood …
Response And Safety Of Treatment Of Chronic Hepatitis C By Direct-Acting Antiviral Drugs In Patients With Child B-Related Cirrhosis, Ayman A. Sakr, Hosam M. Ibrahim, Mohamed R. Moussa
Response And Safety Of Treatment Of Chronic Hepatitis C By Direct-Acting Antiviral Drugs In Patients With Child B-Related Cirrhosis, Ayman A. Sakr, Hosam M. Ibrahim, Mohamed R. Moussa
Menoufia Medical Journal
Objectives To evaluate the response and safety of treatment of chronic hepatitis C virus (HCV) by direct-acting antiviral (DAAs) drugs in patients with Child B-related cirrhosis. Background Chronic HCV infection is considered to be one of the major public health diseases that affect most Egyptian population. The appearance of DAAs with its safety and high successful eradication rates has replaced the old treatment protocols, which used interferon. Patients and methods This was a cross-sectional study to collect data and outcome of chronic HCV-infected patients who were treated with DAAs. Treatment-naive patients without cirrhosis were treated without ribavirin, and those who …